Language Selection

Government of Canada / Gouvernement du Canada
Français

Influenza, Respiratory Viruses and Coronaviruses

<<Return to Search Results

Laboratory Details

Division:
Vaccine Preventable Diseases
Address:
1015 Arlington Street
Winnipeg, Manitoba
R3E 3R2
Email:
Nathalie.Bastien@phac-aspc.gc.ca
Phone #:
(204) 789-6047
Fax:
(204) 789-2082
Description:

The Influenza, Respiratory Viruses and Coronavirus Section undertakes enhanced surveillance, investigations, and research on influenza, SARS-CoV-2, and other respiratory pathogens, as well as develops, evaluates, and improves new molecular techniques and reagents for early detection and identification of potential epidemic and pandemic influenza strains and other new emerging respiratory viruses.

Proficiency Panels

Proficiency Panels
Proficiency PanelPathogen
Detection of Middle East Respiratory Syndrome Coronavirus by PCR Middle East respiratory syndrome coronavirus (MERS-CoV)
Influenza Virus Isolation and Identification Influenza virus
Influenza Virus Molecular Proficiency Testing Influenza virus

Proficiency Panel Reports

Requisition Form

Reference Diagnostic Tests

Reference Diagnostic Tests
PathogenTest CategoryReference Diagnostic Test
Adenovirus Molecular Detection Molecular Detection by PCR or RT-PCR
Adenovirus Genotyping Genotyping by PCR and Sequencing
Human Bocavirus (HBoV) Molecular Detection Molecular Detection by PCR or RT-PCR
Human Coronavirus (HCoV), excluding SARS and MERS Molecular Detection Molecular Detection by PCR or RT-PCR
Human Metapneumovirus (HMPV) Molecular Detection Molecular Detection by PCR or RT-PCR
Human Parainfluenza virus (HPIV) Molecular Detection Molecular Detection by PCR or RT-PCR
Human Rhinovirus Molecular Detection Molecular Detection by PCR or RT-PCR
Influenza A virus Susceptibility Testing Amantadine Susceptibility Testing by Sequencing
Influenza virus Susceptibility Testing Oseltamivir Susceptibility Testing by NA Star and/or Sequencing
Influenza virus Genotyping Genotyping by RT-PCR
Influenza virus Susceptibility Testing Zanamivir Susceptibility Testing by NA Star and/or Sequencing
Influenza virus Strain Characterization Hemagglutination Inhibition (HAI) assay
Middle East respiratory syndrome coronavirus (MERS-CoV) Molecular Detection Molecular Detection by PCR or RT-PCR
Respiratory syncytial virus (RSV) Molecular Detection Molecular Detection by PCR or RT-PCR
SARS-CoV-2 Strain Characterization Antigenic Strain Characterization
SARS-CoV-2 Molecular Detection Molecular Detection by RT-PCR
SARS-CoV-2 Susceptibility Testing Susceptibility testing to Paxlovid and remdesivir
SARS-CoV-2 Sequencing Next Generation Sequencing (NGS)
Severe acute respiratory syndrome associated coronavirus (SARS-CoV) Molecular Detection Molecular Detection by PCR or RT-PCR
Zoonotic Influenza virus Molecular Detection Molecular Detection by PCR or RT-PCR